In a study investigating the efficiency gain in clinical routine with our AI Unilabs reported saving up to 90% diagnostic time compared to manual scoring. In addition, several patients needed to be re-classified leading to the identification of more patients eligible for treatment in the prospective study setting.

Our #ASCO2023 poster on HER2-low was selected for oral presentation by session chair Prof. David Rimm (Yale University School of Medicine). In his discussion he highlighted AI as an essential means to score HER2 in the future.

Our leading ‘0 Click’ AI algorithms are now available through Proscia’s Concentriq© platform used by Clinicians and Pharma R&D alike!